ESMO 2021, the world's premier congress in medical oncology!
The congress will attract an international community of experts, across disciplines and all focused on finding the most effective cancer treatment solutions available today.
This is the ultimate goal of ESMO 2021 and we count on our Industry Partners active in oncology to help us again further our science and improve the lives of patients through continued education.
Fast Facts: ESMO Virtual Congress 2020
- 32 732 participants, 155 countries
- 68 exhibitors
- 453 invited speakers
- 145 sessions, 22 tracks
- 2756 submitted abstracts
How can I participate in 2021?
At ESMO we are committed to providing our industry partners with a variety of solutions to facilitate your presence at our congress.
Contact the ESMO Events Sponsorship Team for more details and we look forward to hearing from you!
Who has already signed up?
We gratefully acknowledge the valuable contribution of the following organisations in the ESMO Congress 2021 through their presence in the virtual exhibition, organisation of sponsored sessions, or via sponsorship activities (as of September 2021):
- AbbVie, Inc.
- Advanced Accelerator Applications International SA
- Agendia
- Alkermes
- Amgen
- Astellas
- AstraZeneca
- Bayer
- BeiGene Switzerland GmbH
- Bionano Genomics
- Boehringer Ingelheim International GmbH
- Boston Scientific International SA
- Bristol Myers Squibb
- Calithera Biosciences
- Caris Life Sciences
- Cerba Research
- Clovis Oncology, Inc.
- Coherus BioSciences
- Daiichi Sankyo, Inc.
- Deciphera Pharmaceuticals
- Eisai Europe LTD
- Eli Lilly and Company
- Elsevier
- Erytech Pharma
- EUSA Pharma
- Exact Sciences International
- Exelixis, Inc.
- F. Hoffmann-La Roche
- Genmab
- Gilead Sciences Europe Ltd.
- GSK
- Guardant Health
- Helsinn Healthcare
- Illumina
- Incyte Biosciences International Sàrl
- Ipsen
- ITM Isotopen Technologien München AG
- Janssen
|
- Jazz Pharmaceuticals
- Kaiku Health
- Kyowa Kirin International
- Labcorp Oncology
- MatchTrial
- medac GmbH
- Medscape Oncology
- Menarini Silicon Biosystems
- Merck KGaA
- Mirati Therapeutics, Inc.
- Molecular Health
- MSD
- Myriad Genetics
- Natera
- NeoGenomics, Inc.
- Novartis Oncology
- Novocure GmbH
- OSE Immunotherapeutics
- Pfizer Oncology
- PharmaMar SA
- Philips Molecular Pathway Diagnostics
- Pierre Fabre
- Precision for Medicine
- Sandoz
- Sanofi Genzyme
- Seagen
- Servier
- Sophia Genetics
- SOTIO a.s.
- Stemline Therapeutics, Inc.
- Syneos Health
- Sysmex Inostics
- Taiho Oncology, Inc.
- Takeda Pharmaceutical Company
- Tempus
- Thermo Fisher Scientific
- Viatris
- VJ Oncology
|
